MeiraGTx is a gene therapy company, which is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The Company is pioneering the use of gene therapy to treat devastating neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. MeiraGTx is also developing innovative gene therapies for ocular diseases including rare inherited blindness and age-related macular degeneration.